arstatinfo.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
User-agent: * Allow: / # Optimization for Google Ads Bot User-agent: AdsBot-Google-Mobile User-agent: AdsBot-Google Disallow: /_api/* Disallow: /_partials* Disallow: /pro-gallery-webapp/v1/galleries/* # Block PetalBot User-agent: PetalBot Disallow: / Sitemap: https://www.arstatinfo.com/sitemap.xml # Auto generated, go to SEO Tools > Robots.txt Editor to change
Meta Tags
Title Arstat Pharmaceuticals |
Description Advancing Transformational Products for Tens of Millions of We are pleased to present Arstat Pharmaceuticals and its transformational women’s health products.
Keywords N/A
Server Information
WebSite arstatinfo faviconarstatinfo.com
Host IP 185.230.63.107
Location -
Related Websites
Site Rank
More to Explore
arstatinfo.com Valuation
US$1,573,671
Last updated: 2023-05-12 03:27:46

arstatinfo.com has Semrush global rank of 6,725,871. arstatinfo.com has an estimated worth of US$ 1,573,671, based on its estimated Ads revenue. arstatinfo.com receives approximately 181,578 unique visitors each day. Its web server is located in -, with IP address 185.230.63.107. According to SiteAdvisor, arstatinfo.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$1,573,671
Daily Ads Revenue US$1,453
Monthly Ads Revenue US$43,579
Yearly Ads Revenue US$522,943
Daily Unique Visitors 12,106
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
arstatinfo.com. A 3599 IP: 185.230.63.107
arstatinfo.com. A 3599 IP: 185.230.63.171
arstatinfo.com. A 3599 IP: 185.230.63.186
arstatinfo.com. NS 86400 NS Record: ns6.wixdns.net.
arstatinfo.com. NS 86400 NS Record: ns7.wixdns.net.
HtmlToTextCheckTime:2023-05-12 03:27:46
top of page Committed to improving women’s health and quality of life Home Team Our Portfolio Nuvocept Premring Enhanta Contact Advancing Transformational Products for Tens of Millions of Women NUVOCEPT TM The first and only contraceptiv e endorsed by the FDA for exclusive testing and labeling for overweight and obese women (≈60% of 10 million US pill users) Learn More Addressing a high public health priority in the post-Roe world PREMRING TM First-in-class medicated vaginal ring for uterine fibroids and endometriosis (>15 million US women) Learn More ENHANTA TM First-in-class single non-hormonal therapy for painful, heavy menstrual periods (>25 million US women) Learn More One of the Best Portfolios in Women’s Health Eleven US Patents, two Phase III-ready products, two potential blockbusters Our Portfolio We are reaching out to partners, executives, and advisors. Contact Us We’re happy to connect! Arkady Rubin, PhD Chief Scientific Officer and Acting CEO Email:
HTTP Headers
HTTP/1.1 301 Moved Permanently
Date: Sat, 27 Nov 2021 07:39:01 GMT
Content-Length: 0
Connection: keep-alive
location: https://www.arstatinfo.com/
strict-transport-security: max-age=120
Age: 66416
Server-Timing: cache;desc=hit, varnish;desc=hit, dc;desc=42
X-Seen-By: 6ivkWfREES4Y8b2pOpzk7Owfbs+7qUVAqsIx00yI78k=,sHU62EDOGnH2FBkJkG/Wx8EeXWsWdHrhlvbxtlynkVjV6gLktDfyBcCbzwqWl25/,m0j2EEknGIVUW/liY8BLLlE5ByQns6DUljTJazv+2SdGkFvVdT2Nq6f3Hedj7ewB,2d58ifebGbosy5xc+FRaljLbvFoyZt4I69Odx0Y+2vjZ9mJcr8u350z1cVyTET0nrepchL+tqOgI91EGOej/Jw==,2UNV7KOq4oGjA5+PKsX47OCjA+c5nRKN7OqsnEUy6YofbJaKSXYQ/lskq2jK6SGP
Cache-Control: no-cache
X-Wix-Request-Id: 1637998741.9831636979128471631
X-Content-Type-Options: nosniff

HTTP/2 200 
date: Sat, 27 Nov 2021 07:39:02 GMT
content-type: text/html; charset=UTF-8
content-length: 460688
link: ; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,
etag: W/"79c0356f35ba9f77d73eba7af3752a43"
content-language: en-US
strict-transport-security: max-age=120
age: 12174
x-seen-by: GXNXSWFXisshliUcwO20NXdyD4zpCpFzpCPkLds0yMeTVP3BWjFd4j+JIEoypGs8,qquldgcFrj2n046g4RNSVN84Ct3gzgkNecxd2YwpvXpYgeUJqUXtid+86vZww+nL,2d58ifebGbosy5xc+FRalmz3CFiWdVHJTAeItoibQ/14mi0U8oqLFxIPoZa+T3bvJr+hgePlhn0qe/rAeYk7Uig1eN+xOCzGro83o6sh3C0=,2UNV7KOq4oGjA5+PKsX47K8pmfvSGistxIwG0wYZgsya46R9xNIlpQ4eUPYpBuqs
cache-control: no-cache
vary: Accept-Encoding
accept-ranges: bytes
x-wix-request-id: 1637998742.188162069742261
set-cookie: ssr-caching=cache#desc=hit#varnish=hit#dc#desc=nane1_g; Max-Age=20; Expires=Sat, 27 Nov 2021 07:39:22 GMT
server-timing: cache;desc=hit, varnish;desc=hit, dc;desc=nane1_g
x-content-type-options: nosniff
server: Pepyaka/1.19.10
via: 1.1 google
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
arstatinfo.com Whois Information
Domain Name: ARSTATINFO.COM
Registry Domain ID: 2349317939_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.networksolutions.com
Registrar URL: http://networksolutions.com
Updated Date: 2020-12-04T12:15:52Z
Creation Date: 2019-01-03T05:23:24Z
Registry Expiry Date: 2023-01-03T05:23:24Z
Registrar: Network Solutions, LLC
Registrar IANA ID: 2
Registrar Abuse Contact Email: abuse@web.com
Registrar Abuse Contact Phone: +1.8003337680
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS6.WIXDNS.NET
Name Server: NS7.WIXDNS.NET
DNSSEC: unsigned
>>> Last update of whois database: 2021-12-08T18:27:11Z <<<